Danimer Scientific Statistics
Share Statistics
Danimer Scientific has 3.02M
shares outstanding. The number of shares has increased by -97.41%
in one year.
| Shares Outstanding | 3.02M |
| Shares Change (YoY) | -97.41% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.03% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 21 |
| FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 494.21K, so undefined% of the outstanding
shares have been sold short.
| Short Interest | 494.21K |
| Short % of Shares Out | n/a |
| Short % of Float | 20.08% |
| Short Ratio (days to cover) | 4.96 |
Valuation Ratios
The PE ratio is -26.77 and the forward
PE ratio is -3.53.
Danimer Scientific's PEG ratio is
1.83.
| PE Ratio | -26.77 |
| Forward PE | -3.53 |
| PS Ratio | 89.15 |
| Forward PS | 0 |
| PB Ratio | 14.97 |
| P/FCF Ratio | -55.53 |
| PEG Ratio | 1.83 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Danimer Scientific.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.87,
with a Debt / Equity ratio of 1.47.
| Current Ratio | 6.87 |
| Quick Ratio | 5.26 |
| Debt / Equity | 1.47 |
| Debt / EBITDA | -4.25 |
| Debt / FCF | -5.44 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $181,649.81 |
| Profits Per Employee | $-604,953.31 |
| Employee Count | 257 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 2.91 |
Taxes
| Income Tax | 319K |
| Effective Tax Rate | -0.21% |
Stock Price Statistics
The stock price has increased by -99.18% in the
last 52 weeks. The beta is 1.63, so Danimer Scientific's
price volatility has been higher than the market average.
| Beta | 1.63 |
| 52-Week Price Change | -99.18% |
| 50-Day Moving Average | 1.08 |
| 200-Day Moving Average | 10.44 |
| Relative Strength Index (RSI) | 23.71 |
| Average Volume (20 Days) | 20,924 |
Income Statement
In the last 12 months, Danimer Scientific had revenue of 46.68M
and earned -155.47M
in profits. Earnings per share was -1.52.
| Revenue | 46.68M |
| Gross Profit | -26.96M |
| Operating Income | -125.62M |
| Net Income | -155.47M |
| EBITDA | -96.13M |
| EBIT | -125.19M |
| Earnings Per Share (EPS) | -1.52 |
Full Income StatementBalance Sheet
The company has 59.17M in cash and 408.07M in
debt, giving a net cash position of -348.9M.
| Cash & Cash Equivalents | 59.17M |
| Total Debt | 408.07M |
| Net Cash | -348.9M |
| Retained Earnings | -454.12M |
| Total Assets | 643.77M |
| Working Capital | 48.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -47.26M
and capital expenditures -27.68M, giving a free cash flow of -74.95M.
| Operating Cash Flow | -47.26M |
| Capital Expenditures | -27.68M |
| Free Cash Flow | -74.95M |
| FCF Per Share | -0.73 |
Full Cash Flow StatementMargins
Gross margin is -57.75%, with operating and profit margins of -269.08% and -333.03%.
| Gross Margin | -57.75% |
| Operating Margin | -269.08% |
| Pretax Margin | -332.35% |
| Profit Margin | -333.03% |
| EBITDA Margin | -205.91% |
| EBIT Margin | -269.08% |
| FCF Margin | -160.55% |
